These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29593850)

  • 1. Systemic delivery of selective EP1 and EP3 receptor antagonists attenuates pentylenetetrazole-induced seizures in mice.
    Reschke CR; Poersch AB; Masson CJ; Jesse AC; Marafiga JR; Lenz QF; Oliveira MS; Henshall DC; Mello CF
    Int J Physiol Pathophysiol Pharmacol; 2018; 10(1):47-59. PubMed ID: 29593850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The roles of prostaglandin E receptor subtypes in the cytoprotective action of prostaglandin E2 in rat stomach.
    Araki H; Ukawa H; Sugawa Y; Yagi K; Suzuki K; Takeuchi K
    Aliment Pharmacol Ther; 2000 Apr; 14 Suppl 1():116-24. PubMed ID: 10807413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of EP receptor subtypes responsible for prostaglandin E2-induced pain responses by use of EP1 and EP3 receptor knockout mice.
    Minami T; Nakano H; Kobayashi T; Sugimoto Y; Ushikubi F; Ichikawa A; Narumiya S; Ito S
    Br J Pharmacol; 2001 Jun; 133(3):438-44. PubMed ID: 11375261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E receptor subtypes involved in stimulation of gastroduodenal bicarbonate secretion in rats and mice.
    Takeuchi K; Ukawa H; Furukawa O; Kawauchi S; Araki H; Sugimoto Y; Ishikawa A; Ushikubi F; Narumiya S
    J Physiol Pharmacol; 1999 Jun; 50(2):155-67. PubMed ID: 10424714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasoconstriction induced by activation of EP1 and EP3 receptors in human lung: effects of ONO-AE-248, ONO-DI-004, ONO-8711 or ONO-8713.
    Norel X; de Montpreville V; Brink C
    Prostaglandins Other Lipid Mediat; 2004 Oct; 74(1-4):101-12. PubMed ID: 15560119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of pentylenetetrazol-induced seizures by prostaglandin E2 receptors.
    Oliveira MS; Furian AF; Rambo LM; Ribeiro LR; Royes LF; Ferreira J; Calixto JB; Mello CF
    Neuroscience; 2008 Apr; 152(4):1110-8. PubMed ID: 18329178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EP2 receptor agonist ONO-AE1-259-01 attenuates pentylenetetrazole- and pilocarpine-induced seizures but causes hippocampal neurotoxicity.
    Santos AC; Temp FR; Marafiga JR; Pillat MM; Hessel AT; Ribeiro LR; Miyazato LG; Oliveira MS; Mello CF
    Epilepsy Behav; 2017 Aug; 73():180-188. PubMed ID: 28645087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of the central prostaglandin EP3 receptors in cardiovascular regulation in rats.
    Ariumi H; Takano Y; Masumi A; Takahashi S; Hirabara Y; Honda K; Saito R; Kamiya HO
    Neurosci Lett; 2002 May; 324(1):61-4. PubMed ID: 11983295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EP1- and EP3-receptors mediate prostaglandin E2-induced constriction of porcine large cerebral arteries.
    Jadhav V; Jabre A; Lin SZ; Lee TJ
    J Cereb Blood Flow Metab; 2004 Dec; 24(12):1305-16. PubMed ID: 15625406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E2 aggravates gastric mucosal injury induced by histamine in rats through EP1 receptors.
    Hase S; Yokota A; Nakagiri A; Takeuchi K
    Life Sci; 2003 Dec; 74(5):629-41. PubMed ID: 14623033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of postsynaptic EP4 and presynaptic EP3 receptors in actions of prostaglandin E2 in rat supraoptic neurones.
    Shibuya I; Setiadji SV; Ibrahim N; Harayama N; Maruyama T; Ueta Y; Yamashita H
    J Neuroendocrinol; 2002 Jan; 14(1):64-72. PubMed ID: 11903814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E prevents indomethacin-induced gastric and intestinal damage through different EP receptor subtypes.
    Kunikata T; Araki H; Takeeda M; Kato S; Takeuchi K
    J Physiol Paris; 2001; 95(1-6):157-63. PubMed ID: 11595431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E2-induced modification of tetrodotoxin-resistant Na+ currents involves activation of both EP2 and EP4 receptors in neonatal rat nodose ganglion neurones.
    Matsumoto S; Ikeda M; Yoshida S; Tanimoto T; Takeda M; Nasu M
    Br J Pharmacol; 2005 Jun; 145(4):503-13. PubMed ID: 15821755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of EP-receptor subtypes involved in allodynia and hyperalgesia induced by intrathecal administration of prostaglandin E2 to mice.
    Minami T; Nishihara I; Uda R; Ito S; Hyodo M; Hayaishi O
    Br J Pharmacol; 1994 Jul; 112(3):735-40. PubMed ID: 7921597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 16,16-Dimethyl prostaglandin E2 inhibits indomethacin-induced small intestinal lesions through EP3 and EP4 receptors.
    Kunikata T; Tanaka A; Miyazawa T; Kato S; Takeuchi K
    Dig Dis Sci; 2002 Apr; 47(4):894-904. PubMed ID: 11991626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E2-prostanoid EP3 signal induces vascular contraction via nPKC and ROCK activation in rat mesenteric artery.
    Kobayashi K; Murata T; Hori M; Ozaki H
    Eur J Pharmacol; 2011 Jun; 660(2-3):375-80. PubMed ID: 21463619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of thermoregulatory and febrile responses in mice deficient in prostaglandin EP1 and EP3 receptors.
    Oka T; Oka K; Kobayashi T; Sugimoto Y; Ichikawa A; Ushikubi F; Narumiya S; Saper CB
    J Physiol; 2003 Sep; 551(Pt 3):945-54. PubMed ID: 12837930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrasting effects of E type prostaglandin (EP) receptor agonists on core body temperature in rats.
    Oka T; Oka K; Saper CB
    Brain Res; 2003 Apr; 968(2):256-62. PubMed ID: 12663095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of prostaglandin E2 receptors in oral squamous cell carcinomas and growth inhibitory effects of an EP3 selective antagonist, ONO-AE3-240.
    Hoshikawa H; Goto R; Mori T; Mitani T; Mori N
    Int J Oncol; 2009 Mar; 34(3):847-52. PubMed ID: 19212690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood-brain barrier dysfunction.
    Lenz QF; Arroyo DS; Temp FR; Poersch AB; Masson CJ; Jesse AC; Marafiga JR; Reschke CR; Iribarren P; Mello CF
    Neuroscience; 2014 Sep; 277():859-71. PubMed ID: 25090924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.